TNFSF14 Protein
Quick Overview for TNFSF14 Protein (ABIN935610)
Target
See all TNFSF14 ProteinsProtein Type
Origin
Source
Purity
-
-
Sequence
- RLGEMVTRLP DGPAGSWEQL IQERRSHEVN PAAHLTGANS SLTGSGGPLL WETQLGLAFL RGLSYHDGAL VVTKAGYYYI YSKVQLGGVG CPLGLASTIT HGLYKRTPRY PEELELLVSQ QSPCGRATSS SRVWWDSSFL GGVVHLEAGE KVVVRVLDER LVRLRDGTRS YFGAFMV
-
Characteristics
-
Purified recombinant Human LIGHT protein
Expression System: Hi-5 cells -
Endotoxin Level
- < 0.1 ng per µg (1 EU/µg).
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System HEK-293 CellsConjugate His tagOrigin HumanPrice starts at $16,231.82Expression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $20,480.57Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Comment
-
Manufactured using (BTI-Tn-5B1-4) cells under license from the Boyce Thompson Institute for Plant Research, Inc.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- Supplied as a lyophilized powder.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- RT/-20 °C
-
-
- TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
-
Background
-
LIGHT belongs to the TNF family of ligands, and can signal through the herpes virus entry mediator type A receptor (HVEM, TNFRSF14), LTbetaR, or bind to a decoy receptor, DcR3. It is expressed in splenocytes, activated PBL, CD+8 tumor infiltrating lymphocytes, granulocytes, and monocytes. LIGHT has the ability to active NF kb, to co-stimulate the activation of lymphocytes and to induce apoptosis in certain human tumor cells.
Alternative Names: CD258 protein, Ligand for herpesvirus entry mediator protein, TNF14 protein, TNFSF14 protein, HVEM-L protein -
Molecular Weight
- 19.3 kDa
-
Pathways
- Cancer Immune Checkpoints
Target
-